3D Printing Medical Devices Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 

Overview:

Global 3D Printing Medical Devices Market size is projected to reach USD 6.86 billion by 2030, as per the report of Market Research at a CAGR of 29.9% during the forecasted period 2023 - 2030, which can be studies as the forecast period for the market. The report also covers several market aspects to understand, which way the market would swing in the coming days.

3D printing has the benefit of creating products with great precision and in much less time. In addition, it curbs the final cost significantly and can be customized as per the need. The recent advents of the technology in various segments like dental, orthopaedic, and others are expected to make substantial space for the market to proliferate. The technology is gaining mileage by impacting sectors like the creation of limb prosthetics, titanium replacements for hips & jaws, manufacturing of plastic tracheal splints, etc.

The global market for 3D printing medical devices can experience the impacts of government funding and various private investors. But its biocompatibility issues can deter the market growth.

Competitive Landscape:

Global 3D Printing Medical Devices Market Players has potential to make changes in the outcome of the market in the coming years by transforming their strategic moves. These companies are Stratasys Ltd., 3D Systems Corporations, EnvisionTEC, Arcam AB, Organovo Holdings, Inc., SLM Solutions Group AG, Materialise NV, Oxford Performance Materials, Inc., Laser GmbH, 3T RPD Ltd, Bio3D Technologies, Renishaw plc, Cyfuse Medical K.K.EOS GmbHConcept, Prodways Group, and others.

 

Segmentation:

MRFR’s take on the Global 3D Printing Medical Devices Market has its foundation on the segments like component, types, application, technology, and end-users. These segments have inclusion of various insights regarding the market that can be explored well for strategies of the coming years.

By type, the global market for 3D printing medical devices includes prosthetics & implants, surgical instruments, surgical guides, and tissue engineering product. The surgical guide segment has better market coverage.

By component, the global market report for 3D printing medical devices comprises system, 3D bio printer, materials software & services, and 3D printer. The software & services segment has better opportunities to cover the market on a greater way.

By technology, the report for 3D Printing Medical Devices Market insights forms a foundation by centering around droplet deposition, 3D printing, laser beam melting, photopolymerization, laminated object manufacturing (LOM), polyjet technology, electron beam melting (EBM), and others. The photopolymerization segmentation is deemed to spearhead the global market.

By application, the same market report covers clinical study devices, external wearable devices, implants, and tissue engineering.

By end-users, the report on the global market for 3D Printing Medical Device comprises academic institutions, medical & surgical centers, pharma & biotech companies, hospitals, and contract research organization.

Regional Analysis:

 

The 3D Printing Device Marketis finding strong traction in the Americas where cosntant changes is getting ushered in by various market players who are operating from the region and impacting the global market by earning better revenues. The market in the Americas has two distinct regions like North America and South America. In North America, the market for 3D printing devices depends mainly on the contributions of the US and Canada, whereas, in the South, the market gains more from the evolution of Argentina and Brazil. North America has the market dominance and it can be taken into consideration The market in the region is gaining from increasing demand for transplants.

In Europe, the market is finding strong growth due to increasing government funding and investments in the research and development sector. The improving lifestyle is also creating much demand for the regional market for 3D printing medical devices.

The market in the Asia-Pacific region has the potential to clock highest growth rate during the forecast period. Also, the geriatric population and rising expenditure in the healthcare sector can improve the market scenario better.

The market from the Middle East & Africa region may find least revenues to contribute as the region lacks infrastructure and much expenditure capacity due to the presence of poor economies.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Robot-Assisted Surgical Systems Market Players, Industry Trends Analysis Report by Technology, By End User & By Product

 

Market Overview

It is projected that the global robot-assisted surgical system market size is projected to reach USD 6.99 billion by 2030 at a CAGR 16.5% During the forecast period 2022-2030. Medical robotics technology is undergoing a tremendous transformation. Advancements in various fronts are being observed, which is providing an impetus to the application potential of healthcare robotics. The arrival of 3D imaging, HD surgical microscopic cameras, robotic catheter control system (CCS), data recorders & data analytics and remote navigation has enabled the undertaking of highly complex surgical produces.

The growing need for high surgical accuracy is driving the adoption of robot-assisted surgical systems. Moreover, an increased number of surgical procedures due factors such as a higher prevalence of trauma injuries, and rising geriatric population. Healthcare robotics boasts a strong R&D pipeline, which indicates towards a brighter future. Companies are actively focusing on devloping innovative products and their fast commercialization. For instanace, the US FDA approved Intuitive Surgical’s the da Vinci SP surgical system, which can be used in critical urologic surgical procedures in May 2018. However, the path is not without hurdles, high cost of such devices market customer pool limited. Product penetration remains sluggish in price-sensitive markets.

 

Global Robot-Assisted Surgical Systems Market: Competition Analysis

The Robot-Assisted Surgical Systems Market Players are Renishaw Plc, Stryker Corporation (MAKO Surgical Corp.), Accuracy, Health Robotics S.R.L.,Auris Surgical Robotics, Inc. (Hansen Medical Inc.), Medtronic plc, Zimmer Biomet Holdings Inc., Verb Surgical,Titan Medical, Microbot Medical, Varian, Smith & Nephew Plc. (Blue Belt Technologies, Inc.), Transenterix, KUKA AG, Medrobotics, Intuitive Surgical Inc, THINK Surgical Inc., and Mazor Robotics are among the key companies profiled in MRFR’s report.

 

Global Robot-Assisted Surgical Systems Market: Segmental Analysis

The segmental analysis of the global robot-assisted surgical systems market has been conducted on the basis of end user, product, and application.

On the basis of end user, the market has been segmented into healthcare payers, healthcare providers and others. Based on product, the market has been segmented into rehabilitation robots, hospital and pharmacy robots, emergency response robotic systems, surgical robots and non-invasive radiosurgery robots. The rehabilitation robots segment covers prosthetics, therapeutic robots, robotic exoskeleton systems, orthotics and assistive robots. The hospital and pharmacy robots segment covers IV robots, cart transportation robots, pharmacy robots and telemedicine robots. The surgical robot segment covers laparoscopy robotic systems, robotic neurosurgical systems, and orthopedic surgical robots. Categories of laparoscopy robotics systems include Da Vinci robotic surgery system, Steerable Robotic Catheters, FreeHand endoscope holder system and Telelap ALF-X surgical system. Categories of robotic neurosurgical systems include NeuroMate surgical system, Renaissance surgical system and Pathfinder surgical system. Categories of orthopedic surgical robots include Robodoc surgical system, iBlock surgical system, MAKO RIO surgical system, Stanmore Sculptor surgical system and Navio PFS surgical system. On the basis of application, the market has been segmented into orthopedics robotic systems, special education, laparoscopy and neurology.

 

Global Robot-Assisted Surgical Systems Market: Regional Analysis

The regional analysis of the robot assisted surgical market insights has been conducted across the Middle East and Africa (MEA), Asia Pacific (APAC), Europe, and the Americas. In MEA, the market has been assessed in GCC countries and Africa. In APAC, countries such as China, Japan, India, South Korea, Australia, among others are covered. In the report, the Europe market has been segmented into Western and Eastern Europe. In West Europe, countries such as Germany, France, Italy, Spain, and the UK were under the spotlight. The Americas market has been segmented into Latin America and North America. In North America, the U.S. and Canada are covered.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Influenza Diagnostics Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 

Market Overview

Market Research Future (MRFR) has published a report about the global influenza diagnostics market size expects 5.3% CAGR during the forecast period between 2022-2030. In terms of cash, this market is expected to grow with USD 1.63 billion by 2030. This report analyzes the market, potential for growth during the forecast period, market sizes around the world, key players in the market, product launches and latest research and development (R&D).

Influenza as an illness can cause severe complications and mess up anybody's medical history. Influenza is of various types and with a variety of deadly symptoms. Hence, early diagnosis of influenza can reduce the chances of further complications. Therefore, with World Health Organization (WHO) confirming about 600 million Influenza cases worldwide, the services offering accurate Influenza diagnosis are going to be in-demand always and become a part of a huge market in the medical sector.

Key Players

Global influenza diagnostics market players include Alere (USA), BD (USA), Becton Dickinson (USA), BioMérieux SA (France), Cepheid (USA), Hardy Diagnostics(USA), LifeSign LLC.(USA), Meridian Bioscience, Inc.(USA), Quidel Corporation (USA), Roche Molecular Systems Inc.(Switzerland), and Sekisui Diagnostics (USA).

Market Segmentation

The global influenza diagnostics market is segmented on the basis of types, tests, and region. The segmentation of types comprises of type A flu, type B flu, type C flu. The three forms of type A are bird flu, seasonal flu, and Swine flu. Bird Flu is known as Avian Influenza which is caused by viruses adapted to birds. It can be caused by eating infected birds. Seasonal flu is common cold whose viruses become active only during the change of seasons as human body becomes adapt to the new season slowly. Similar to bird flu, swine flu is an infection caused by any one of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) are the viruses causing this infection. These viruses are found in pigs. Type B flu is found only in humans. Influenza type B viruses are not classified by subtype and do not cause pandemics. It is caused by a genus called Influenzavirus B which is from the virus family Orthomyxoviridae. Type C Influenza viruses are from Orthomyxoviridae family. They are not as severe as Type A or B but can cause local epidemics.

On the basis of tests, the market has been segmented into direct fluorescent antibody (DFA) tests, molecular tests, nucleic acid sequence-based amplification (NASBA) tests, rapid influenza detection tests (RIDT), serological assays, simple amplification-based assays (SAMBA) and loop-mediated isothermal amplification-based assays (LAMP). RITD is the most common test for influenza, as it can confirm influenza in just 30 minutes.

Serological assays are segmented into primary serological tests, secondary serological tests, and tertiary serological tests. Primary serological tests cover enzyme-linked immunosorbent assay (ELISA), immunofluorescent antibody technique (IFAT) and radioimmunoassay (RIA). Secondary Serological tests include agglutination tests, complement fixation tests (CFT), precipitation tests, serum neutralization tests (SNT) and toxin-antitoxin test.

Regional Analysis

The regional segmentation of the global influenza diagnostics market insight is into the Americas (North America & South America), Europe, Asia Pacific, and Middle East & Africa (MEA). North America is believed to be the largest market for global influenza diagnostics due to advanced healthcare facilities and the increasing presence of major market players in this region. Compared to North America, South America is a moderately smaller market, but that is not due to lack of demand but due to the lack of awareness, lack of advanced technology and lesser budgets for healthcare. In North America, the largest markets are Canada and the United States of America (USA).

After North America, Europe is the largest market for influenza diagnostics. Here due to reasons same as North America, Western Europe stands with the lion's share in Europe market, compared to Eastern Europe. In Western Europe, the biggest markets are France, Germany, Italy, Spain and the United Kingdom (UK), followed by the rest of Europe.

During the forecast period, Asia Pacific region is expected to experience large-scale growth of influenza diagnostics market with China, India, Japan and South Korea emerging as major markets. Remarkable growth is also expected in remaining countries of Asia Pacific region.

 However, compared to the Asia Pacific, MEA is expected to have limited growth, with Egypt, Saudi Arabia and the United Arab Emirates (UAE) emerging as the best bets for influenza diagnostics market investors. The low market in the MEA region is primarily due to the lack of technology and education.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Bioadhesive Market Insights To Witness Notable Growth During the Forecast Period 2022-2030

 

 

Global Bioadhesive Market: Overview

The Global Bioadhesive Market size is expected is expected to grow USD9.26 billion with a CAGR of 6.80% during the forecast period 2023-2030. According to a recent study report published by the Market Research Future, the global bio adhesive market is expected to gain eminence over the forecast period. The market is forecast to demonstrate a solid growth by 2030 with a remarkable CAGR during the expected period from 2022 – 2030.

Over the last decade, bioadhesives have been considered a potential drug delivery system for oral administration that includes nasal spray, ear drops, eye drops, and ointment hydrogel among others. Bio adhesives are polymers that act as adhesives that contain protein and carbohydrates as major constituents. They are either natural or synthetic polymers. Naturals bio adhesive involve the use of microorganisms like bacteria, fungi, algae, etc. Synthetic polymers are made from biological monomers like sugars. Bio adhesives have number of advantages encouraging their use in healthcare involves their extensive application in drug delivery and tissue repair. They are primarily employed in end user industries such as healthcare, biotechnology, research institutes, packaging industries, etc. The demand of bio adhesives is increasing sue to increase in end users industries.

Global Bioadhesive Market   - Competitive Analysis

The bioadhesive industry has turned into a critical and element power in the global healthcare industry. Through extensive research, it is found out that there has been an extensive utilization in packaging and durability in the market. As there are plenty of large and small market players available. Global Bioadhesive Market Players operating in this market are Bioadhesive Alliance Inc., Camurus, Henkel Corporation, Ashland Inc., 3M Company, Adhesives Research, Yparex B.V., EcoSynthetix Inc., Adhbio and others.

Global Bioadhesive Market   - Regional Analysis

Global bio adhesive market insights is segmented into four key regions: Americas, Europe, Asia-Pacific and Middle East and Africa. Europe is the largest market for bio adhesives in terms of production. Majority of bio adhesive manufacturers in Europe export their products to North America and Asia-Pacific. Increase in research and development activities in bio adhesives favor the growth of this market in Europe. Moreover, biotechnology and research laboratories use bio adhesives on a large scale in this region. America is the second largest market for bio adhesives due to increase in demand of eco-friendly bio adhesive for tissue repair and drug delivery that has favoured the growth of this market in America. Growing emphasis on personal care also increase the demand of bio adhesives in America. Asia-Pacific market is expected to show steady growth in the bio adhesive market during the forecasted period. Japan and India import bio adhesives from European companies which is signifies that there is an increasing demand for bio adhesives for Asia-Pacific for bio adhesive. Middle East and Africa show slow growth in this market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Cardiovascular Application Market Players, Industry Trends Analysis Report by Technology, By End User & By Product

 

Market Overview:

Market Research Future (MRFR) has published a report stating that the global cardiovascular application market size is market to expand at a notable CAGR of 7.10% during the forecast period of 2022-2030 and reach the valuation of USD 32021.96 Mn by the end of 2030. Rapid advancement in technology is aiding the healthcare sector for the development of high-tech medical devices that can be used to ensure proper functioning of vital organs. Cardiovascular application includes the use of synthetic materials and advanced medical devices to help control abnormal functioning of the heart.

Key Players:

Global cardiovascular application market players that are Abbott (the U.S.), General Electric Company (the U.S.), Medtronic (Ireland), Boston Scientific Corporation (the U.S.), KONINKLIJKE PHILIPS N.V. (The Netherlands), Terumo (Japan), Stryker Corporation (the U.S.), Edwards Lifesciences (the U.S.), Allergan Inc. (the U.S.), Smith & Nephew plc (the U.K), CR Bard Inc. (the U.S.), Sonova Holdings (Switzerland), and Dragerwerk AG & Co. KGa (Germany)

 

Market Drivers and Restraints:

Increasing prevalence of cardiovascular diseases caused due to changing lifestyle and rapid rise in geriatric population are inducing high demand for advanced medical devices, resulting in the significant expansion of the global cardiovascular application market. The introduction of upgraded versions of pacemakers that can be integrated with smartphones to keep a real-time check on the functioning of the heart is impacting positively on the growth of the global cardiovascular application market. However, lack of awareness regarding advanced medical devices, high cost of treatment and medical devices and poor healthcare facilities in the underdeveloped regions are likely to pose potential threat for the growth of the global cardiovascular application market during the forecast period.

Market Segmentation:

The global cardiovascular application market insights has been segmented on the basis of devices and end users. Based on devices, the cardiovascular application market has been segmented into cardiac pacemaker, cardiac defibrillators, cardiac monitors, and others. The cardiac monitors segment is sub-segmented into resting ECG, ECG monitors, holter monitors, implantable loop recorder, and others. The cardiac defibrillator segment is sub-segmented into implantable cardioverter defibrillator and external defibrillator. The cardiac pacemaker segment is sub-segmented into implantable cardiac pacemaker and external cardiac pacemaker. The implantable cardiac pacemaker sub-segment includes single-chamber pacemakers, dual-chamber pacemakers, and biventricular pacemakers.

Based on end users, the cardiovascular application market is segmented into cardiac care centers, ambulatory centers & home care, academic institutes, and others. 

Regional Analysis:

Geographically, the global cardiovascular application market has been segmented into four major regions such as the Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas account for a major market share in the global cardiovascular application market owing to the rapid development of advanced medical devices in the well-developed healthcare sector of this region and increasing incidences suffering from cardiovascular disorders as a result of changing lifestyle.

 

The cardiovascular application market in the Europe region is expanding at a noteworthy growth rate due to rise in prevalence of diabetes and cardiovascular diseases and high healthcare expenditure by the population in this region. The Asia Pacific region is projecting fastest growth in the global cardiovascular application market due to the increasing government support for development of affordable treatments and rise in adoption of advanced cardiovascular devices in the emerging economies in this region. The cardiovascular application market is projecting slow growth in the Middle East and Africa region due to the unavailability of proper health care services in the underdeveloped areas of this region.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Biologic Therapy Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 

Global Biologic Therapy Market to Grow Healthily over 2023

Biologic therapy is gaining traction. According to a report published by Market Research Future (MRFR), the global biologic therapy market size is set to reach USD 288.03 billion by 2030 at a CAGR 8.20% over the forecast years 2023-2030. Biologic therapy is viewed as an innovative treatment module based on products sourced from living organisms.

Biologic therapy is used to stimulate or suppress the immune system for treatment purposes. The therapy finds application in treatment of diseases such as infection, cancer and several other diseases. Advances in the field of biologic therapeutic is boosting the application scope of biologic therapy. Rising demand for biological and targeted drug therapies is making a positive impact on the global biological therapy market. The R&D pipeline for biologic therapy is expected to grow in the future as pharmaceutical companies realise the vast market opportunities. 

Global Biologic Therapy Market: Competition Analysis

Global biologic therapy market players include Bristol-Myers Squibb, Amgen Inc., Eli Lilly, Seattle Genetics, Inc., GlaxoSmithKline Plc., Novartis International AG, Celgene Corporation and Spectrum Pharmaceuticals, Inc.

Global Biologic Therapy Market: Segmental Analysis

MRFR’s report includes a detailed segmental analysis of the market based on therapy, product type, end-user and application. Based on therapy, the market has been segmented into vaccines therapy, cell therapy, protein therapy and others. Based on product type, the market has been segmented into services, instruments and kit and reagents. Based on end-user, the market has been segmented into hospitals and clinic, research centers and speciality centers. Based on application, the market has been segmented into blood and blood-related products testing, tissue and tissue-related products testing, vaccine and therapeutics development, stem cell research and cellular and gene therapy.

Global Biologic Therapy Market: Regional Analysis

On the basis of region, the biologic therapy market insights has been segmented into North America, Europe, the Middle East & Africa (MEA), Latin America and Asia Pacific (APAC). North America represents an important market for biologic therapy. Rising geriatric population, growing cancer prevalence in countries such as the U.S. and Canada are some of the factors supporting the market growth in the region. Data released by United States Census Bureau reveals that the total count of Americans aged 65 and above surpassed 49.2 Mn in 2016. Advanced countries in North America have robust health coverage policies along with a quicker access to latest biologic therapeutics. Many market players operating in North America are focusing on patient-centric products. In addition, companies are focusing on delivering customized therapeutics. High healthcare spending in the region is also influencing the market growth. The Center for Disease Control and Prevention reported that healthcare expenditure in the U.S reach to 3.2 trillion in 2015.

Europe in hold the second spot in the global biologic therapy market in terms of revenue. The market in Europe is expected to exhibit a healthy growth over the next couple of years. The healthcare sector remains focused on innovation and continue to excel in delivering quality care. In addition, presence of an advanced healthcare system is reflecting favourably on the market in the region. Many of the advanced countries in Europe have large pool of geriatric population. Data released by Eurostat revealed that more that 19% of the over population in Europe is aged 65 and above.

Asia Pacific is emerging as a highly attractive market for biologic therapy. It is projected that the market in APAC will demonstrate the fastest growth during the forecast period. Increased occurrence of lifestyle diseases is driving the demand for biologic therapy. Rising healthcare expenditure, increased awareness level and improving healthcare infrastructure are some of the key factors influencing the market in APAC.

The market in MEA is expected to witness a relatively slower growth during the forecast period. This is mainly owing low penetration and limited access. However, increased efforts towards improving healthcare standard in GCC countries is likely to create market opportunities.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America